Veru Inc. (VERU) Financials

VERU Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 50.6 million 32.8 million
2023-06-30 75.2 million 40.8 million
2023-03-31 70.3 million 53.5 million
2022-12-31 103.8 million 54.7 million

VERU Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -9.7 million 4.7 million
2023-06-30 -18.5 million 4.6 million
2023-03-31 -25.7 million 3.8 million
2022-12-31 -34.8 million 4.8 million

VERU Net Income

No data available :(

VERU Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 9.6 million - 4.7 million
2023-06-30 16.2 million - 4.9 million
2023-03-31 23.5 million - 4.0 million
2022-12-31 46.9 million - 4.9 million

VERU Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 85.0 million
2023-06-30 88.3 million
2023-03-31 80.8 million
2022-12-31 80.6 million

VERU Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 212874 6.6 million 6.8 million -
2023-06-30 25674 2.9 million 6.6 million -
2023-03-31 141587 22.9 million 12.8 million -
2022-12-31 285565 18.7 million 17.5 million -

VERU Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 3.9 million 2.3 million
2023-06-30 3.3 million 2.1 million
2023-03-31 6.6 million 2.5 million
2022-12-31 2.5 million 1.8 million

VERU

Price: $1.64

52 week price:
0.36
1.92

Payout Ratio Range:
45.50%
105.30%

Earnings Per Share: -0.70 USD

P/E Ratio: -0.38

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 2.1 million

Ebitda: -7.3 million

Market Capitalization: 192.5 million

Average Dividend Frequency: 4

Links: